Changes in Plasma Amyloid β 1–42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer’s Disease Using an Immunomagnetic Reduction Assay
ACS Omega · 30.06.2026 · 11 (25) · 36855-36865
DOI: 10.1021/acsomega.6c00355 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 15.06.2026. Verfasst von Shieh-Yueh Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: MagQu Co., Ltd., New Taipei City 231, Taiwan. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Neurological Disorders and Stroke, Arizona Department of Health Services, Michael J. Fox Foundation for Parkinson's Research.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- MagQu Co., Ltd., New Taipei City 231, Taiwan.
- Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
ORCID-Profile: Shieh-Yueh Yang, Ming-Jang Chiu
Förderung
- National Institute of Neurological Disorders and Stroke
- Arizona Department of Health Services
- Michael J. Fox Foundation for Parkinson's Research
- National Institute on Aging
- Gates Ventures
- Arizona Biomedical Research Commission
Zitieren
APA
Yang, S. Y., Liu, H. C., Chiu, M. J., Chang, J. F., Ho, C. S., & Lee, K. H. (2026). Changes in Plasma Amyloid β 1–42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer’s Disease Using an Immunomagnetic Reduction Assay. ACS Omega, 11(25), 36855-36865. https://doi.org/10.1021/acsomega.6c00355
Vancouver
Yang SY, Liu HC, Chiu MJ, Chang JF, Ho CS, Lee KH. Changes in Plasma Amyloid β 1–42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer’s Disease Using an Immunomagnetic Reduction Assay. ACS Omega. 2026;11(25):36855-36865. doi:10.1021/acsomega.6c00355
BibTeX
@article{Yang2026,
author = {Yang, Shieh-Yueh and Liu, Huei-Chun and Chiu, Ming-Jang and Chang, Jui-Feng and Ho, Chia-Shin and Lee, Kun-Hung},
title = {Changes in Plasma Amyloid β 1–42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer’s Disease Using an Immunomagnetic Reduction Assay},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {25},
pages = {36855--36865},
doi = {10.1021/acsomega.6c00355}
}
EUVIMED